Indaptus Therapeutics, Inc. (INDP) vs Puma Biotechnology, Inc. (PBYI)

• Indaptus Therapeutics, Inc. INDP 3.34 ▲ +5.70%
• Puma Biotechnology, Inc. PBYI 8.27 ▼ −15.35%

Indaptus Therapeutics, Inc. and Puma Biotechnology, Inc. are both Biotechnology companies. Indaptus Therapeutics, Inc. and Puma Biotechnology, Inc. are of similar size ($504.3M and $485.3M). Indaptus Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Puma Biotechnology, Inc. trades at 15.3×. Puma Biotechnology, Inc. has the higher net margin (11.6% vs 0.00%) and the higher return on invested capital (42.6% vs 0.00%). Across the 13 metrics below, Puma Biotechnology, Inc. leads on 11 and Indaptus Therapeutics, Inc. on 2.